We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
100 result(s) found, displaying 51 to 60
-
Prescription medicine registrationActive ingredients: emtricitabine; tenofovir alafenamide fumarate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottle.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Remdesivir
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle.
-
Prescription medicine decision summaryTGA decision: Veklury (remdesivir) is provisionally approved to treat Coronavirus Disease 2019 (COVID-19) in adults and adolescents
-
Prescription medicine registrationActive ingredients: remdesivir.
-
-
Prescription medicine registrationActive ingredients: T Cells - axicabtagene ciloleucel, cryopreserved - T - Yescarta.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VEMLIDY tenofovir alafenamide (as fumarate) 25 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle.